Commentary: Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?

Autor: Lee RM; Division of Surgery, Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Tex., Antonoff MB; Division of Surgery, Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Tex. Electronic address: mbantonoff@mdanderson.org.
Jazyk: angličtina
Zdroj: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2024 Aug; Vol. 168 (2), pp. 429-430. Date of Electronic Publication: 2024 Jan 20.
DOI: 10.1016/j.jtcvs.2024.01.025
Abstrakt: Competing Interests: Conflict of Interest Statement The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Databáze: MEDLINE